Fund Holdings — Enavate Sciences GP, LLC

Total Portfolio Value
$176.54M
Total Bought
$0
Total Sold
$0
Net Transaction
$0
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
SIONNA THERAPEUTICS INC(SION)2,478,0302,478,030025,92042,99424.35%+17,074
IMMUNOME INC(IMNM)4,768,5834,768,583032,09344,34825.12%+12,255
UPSTREAM BIO INC(UPB)2,459,7032,459,703015,05327,00815.30%+11,954
ZENAS BIOPHARMA INC(ZBIO)3,761,3593,761,359029,71536,44820.65%+6,733
COMPASS THERAPEUTICS INC(CMPX)7,788,1507,788,150014,79720,24911.47%+5,452
CAMP4 THERAPEUTICS CORP(CAMP)3,785,8023,785,802015,1435,4893.11%-9,654
Page 1 of 1
Enavate Sciences GP, LLC — 13F Holdings — Q2 2025 | TickerTrail